Notably, the LSPR sensor successfully detected elevated levels of CD44 and CD133 in blood and CSF from a glioblastoma mouse model, highlighting its clinical potential for minimally invasive, multi-biomarker liquid biopsy diagnostics in GBM monitoring. Here, CD44 is linked to glioblastoma.